4 healthcare shares I want to buy for long-term growth

The healthcare sector is one of the best places to be invested in my opinion. Its defensive and growing earnings make a strong combination.

I am very interested in the following four companies for my portfolio:

NIB Holdings Limited (ASX: NHF)

NIB is one of Australia’s largest private health insurers with a market capitalisation of $2.52 billion.

Private health insurers benefit from all the different types of healthcare needs, which makes it a good investment to gain broad exposure to the healthcare industry.

NIB has been performing very well, it has grown its number of policyholders at an impressive rate over the last few years.

It’s currently trading at a reasonable 21x FY17’s estimated earnings with a grossed-up dividend yield of 4.36%.

Sonic Healthcare Limited (ASX: SHL)

Sonic is one of the biggest healthcare businesses in Australia with a market capitalisation of $9.4 billion.

It is a large pathology business with operations in several countries. In the May budget the government announced that Medicare will pay a higher amount for pathology, which should boost Sonic’s Australian business.

Sonic is trading at 20.5x FY17’s estimated earnings with a partially franked dividend yield of 3.36%.

1300 Smiles Limited (ASX: ONT)

1300 Smiles is one of Australia’s largest dental businesses with a market capitalisation of $138 million.

The business has come up with a clever way of providing affordable care, whilst also generating recurring revenue and loyalty. It has a $1 a day dental plan which is proving to be very popular.

1300 Smiles is trading at 22x FY16’s earnings with a grossed-up dividend yield of 4.68%.

Nanosonics Ltd. (ASX: NAN)

Nanosonics is the company behind a disinfectant medical device that uses ultrasound probes. It has a market capitalisation of $881 million which is growing quickly.

There is a huge potential market for Nanosonics’ devices in thousands of medical facilities across Europe and America. Management are making good progress growing sales, particularly as hygiene requirements increase around the world.

Foolish takeaway

The healthcare sector is definitely one of the best places for your capital over the next few years in my opinion. The above four options, as well as Ramsay Health Care Limited (ASX: RHC) and Healthscope Ltd (ASX: HSO), would be good for any investor.

At the current prices, I think NIB Holdings and 1300 Smiles look like the best long-term buys to me because of how much growth the companies can still achieve.

For more great growth businesses you should read this.

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks means stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

If you're expecting to see the likes of Commonwealth Bank, Telstra and Wesfarmers shares on this list, you'll be sorely disappointed. Not only are their dividends growing at a snail's pace, their profits are under pressure too due to the increasing competitive environment.

The contrast to these "new breed" blue chips couldn't be greater... especially the very real prospect of significant share price gains, something that's looking less likely from the usual blue chip suspects.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Tristan Harrison owns shares of HEALTHSCPE DEF SET and Ramsay Health Care Limited. The Motley Fool Australia owns shares of Nanosonics Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.